What is MYL stock?
William Smith
Updated on February 07, 2026
What is MYL stock?
Performance Outlook
| Previous Close | 13.42 |
|---|---|
| Day’s Range | 13.42 – 13.42 |
| 52 Week Range | 10.83 – 15.50 |
| Volume | 0 |
| Avg. Volume | 307 |
Is MYL stock a buy?
Mylan has received a consensus rating of Hold. The company’s average rating score is 2.33, and is based on 1 buy rating, 2 hold ratings, and no sell ratings.
Is Mylan a good company to invest in?
Mylan (MYL) is a stock many investors are watching right now. MYL is currently sporting a Zacks Rank of #2 (Buy), as well as a Value grade of A. The stock has a Forward P/E ratio of 4.92. Over the past 52 weeks, MYL’s Forward P/E has been as high as 6.47 and as low as 3.83, with a median of 4.45.
Is Mylan Pharmaceuticals publicly traded?
Stock. In 1973, Mylan became a publicly traded company on the OTC market under the ticker symbol MYLN, and in 1976 moved to NASDAQ. Their final stock move was in 1986, when their stock became available for trade on the New York Stock Exchange under the ticker symbol MYL. Currently, the stock is traded on the NASDAQ.
Who did MYL?
Pfizer’s Upjohn spinoff completes merger with Mylan to form Viatris. Pfizer (NYSE:PFE) completes the deal to spin off its Upjohn business and combine it with Mylan NV (MYL) to form Viatris (NASDAQ:VTRS), which will start trading tomorrow under the ticker symbol VTRS.
Can you buy Viatris stock?
You may purchase additional Viatris stock at any time through a broker.
Should I invest in Viatris?
One cheap stock worth considering is drugmaker Viatris (NASDAQ:VTRS). It trades at a ridiculously low price-to-earnings ratio of 4.2 and recently announced its first quarterly results and dividend payment. Viatris looks incredibly attractive at these levels, and its business is beginning to show signs of stability.
Does Mylan pay a dividend?
From their web site: “Mylan does not pay a dividend to holders of its common stock.”
How do I buy stock in Mylan?
How to buy Mylan Stocks & Shares to Invest in MYL Steps of buying Mylan shares
- Step 1: find a good online broker.
- Step 2: open your brokerage account.
- Step 3: deposit money to your account.
- Step 4: buy the Mylan share.
- Step 5: review your Mylan position regularly.
How many employees does Mylan Pharmaceuticals have?
35,000 employees
How many Employees does Mylan have? Mylan has 35,000 employees.
Is Viatris a buy or sell?
Currently, Viatris trades at a forward P/E of just 4.2, making it one of the cheapest stocks on the market today. The consensus among analysts on Wall Street is that the stock will rise by 50% over the next year.
What is Mylan’s new name?
Viatris
Mylan NV is now Viatris with combination with Upjohn – Pittsburgh Business Times.
What is the current stock price of Mylan?
Going by the historical performance, we believe that the stock price of Mylan, a pharmaceutical company best known for its generic drugs, could offer an upside of over 45% from the current levels. MYL stock trades at $15 currently and it is down 35% from the pre-Covid high of $23 seen in February…
What kind of business does Mylan NV do?
Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World.
Where does Mylan’s generic pharmaceutical business take place?
The Generic pharmaceutical business is conducted primarily in the U.S. and Canada; Europe; and India, Australia, Japan, New Zealand and Brazil as well as its export activity into emerging markets. The Specialty pharmaceutical business is conducted by Mylan Specialty L.P.. The company was founded on July
How much money does Mylan and Pfizer make?
The combined entity could generate sales of over $20 billion by 2020, and Pfizer will hold a 57% stake in the new company, with Mylan holding the rest. In this note …
How big is the market cap of Mylan?
Market Cap $13.8B Mylan N.V., is a pharmaceutical company which develops, licenses, manufactures, markets and distributes generic, branded generic and specialty pharmaceutical products. It operates through two segments: Generic and Specialty. The Generic pharmaceutical business is conducted primarily in the U.S.
Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World.
The Generic pharmaceutical business is conducted primarily in the U.S. and Canada; Europe; and India, Australia, Japan, New Zealand and Brazil as well as its export activity into emerging markets. The Specialty pharmaceutical business is conducted by Mylan Specialty L.P.. The company was founded on July
The combined entity could generate sales of over $20 billion by 2020, and Pfizer will hold a 57% stake in the new company, with Mylan holding the rest. In this note
